These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 1346563)

  • 1. Suppression of epicutaneous reactivity by terfenadine and loratadine.
    Small P
    Ann Allergy; 1992 Jan; 68(1):30-4. PubMed ID: 1346563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicentric study of loratadine, terfenadine and placebo in patients with seasonal allergic rhinitis.
    Horak F; Bruttmann G; Pedrali P; Weeke B; Frølund L; Wolff HH; Christophers E
    Arzneimittelforschung; 1988 Jan; 38(1):124-8. PubMed ID: 2896508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Onset of action of loratadine and placebo and other efficacy variables in patients with seasonal allergic rhinitis.
    Bédard PM; Del Carpio J; Drouin MA; Yang W; Hébert J; Lavoie A; Prévost M; Turenne Y; PetitClerc C; Lorber R
    Clin Ther; 1992; 14(2):268-75. PubMed ID: 1351796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relative potency of fexofenadine HCl 180 mg, loratadine 10 mg, and placebo using a skin test model of wheal-and-flare suppression.
    Kaliner MA; White MV; Economides A; Crisalida T; Hale M; Liao Y; Christian CD; Georges GC; Woodworth TH; Meeves SG
    Ann Allergy Asthma Immunol; 2003 Jun; 90(6):629-34. PubMed ID: 12839321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine and placebo in healthy volunteers.
    Rosenzweig P; Caplain H; Chaufour S; Ulliac N; Cabanis MJ; Thebault JJ
    Br J Clin Pharmacol; 1995 Nov; 40(5):459-65. PubMed ID: 8703650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects.
    Simons FE; McMillan JL; Simons KJ
    J Allergy Clin Immunol; 1990 Oct; 86(4 Pt 1):540-7. PubMed ID: 1977781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loratadine (SCH29851) 40 mg once daily versus terfenadine 60 mg twice daily in the treatment of seasonal allergic rhinitis.
    Bruttmann G; Pedrali P
    J Int Med Res; 1987; 15(2):63-70. PubMed ID: 2884152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonsedating antihistamines: pharmacology, clinical efficacy and adverse effects.
    Kaliner MA
    Am Fam Physician; 1992 Mar; 45(3):1337-42. PubMed ID: 1347437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of loratadine (10 mg once daily), terfenadine (60 mg twice daily), and placebo in the treatment of seasonal allergic rhinitis.
    Del Carpio J; Kabbash L; Turenne Y; Prevost M; Hebert J; Bedard PM; Nedilski M; Gutkowski A; Schulz J
    J Allergy Clin Immunol; 1989 Nov; 84(5 Pt 1):741-6. PubMed ID: 2572617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the efficacy and safety of loratadine, terfenadine, and placebo in the treatment of seasonal allergic rhinitis.
    Gutkowski A; Bedard P; Del Carpio J; Hebert J; Prevost M; Schulz J; Turenne Y; Yeadon C
    J Allergy Clin Immunol; 1988 May; 81(5 Pt 1):902-7. PubMed ID: 2897388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the histamine wheal by ebastine compared with cetirizine, fexofenadine and loratadine at steady state.
    Carey W; Warrington S; Boyce M; Luria X
    Drugs Exp Clin Res; 2002; 28(6):243-7. PubMed ID: 12776578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative efficacy of once daily loratadine versus terfenadine in the treatment of allergic rhinitis.
    Banov CH
    J Int Med Res; 1989; 17(2):150-6. PubMed ID: 2566536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria.
    Belaich S; Bruttmann G; DeGreef H; Lachapelle JM; Paul E; Pedrali P; Tennstedt D
    Ann Allergy; 1990 Feb; 64(2 Pt 2):191-4. PubMed ID: 1967919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral H1-blockade effect of fexofenadine.
    Simons FE; Simons KJ
    Ann Allergy Asthma Immunol; 1997 Dec; 79(6):530-2. PubMed ID: 9433369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antihistaminic treatment of allergic rhinitis: a double-blind study with terfenadine versus dexchlorpheniramine.
    Pastorello EA; Ortolani C; Gerosa S; Pravettoni V; Codecasa LR; Fugazza A; Zanussi C
    Pharmatherapeutica; 1987; 5(2):69-75. PubMed ID: 2889217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative antihistamine and anti-allergic effects of various antihistamine preparations].
    Fridliand DG; Gushchin IS; Poroshina IuA; Shul'zhenko AE
    Ter Arkh; 2002; 74(3):67-72. PubMed ID: 11980129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of histamine- and allergen-induced skin reactions: comparison of first- and second-generation antihistamines.
    dos Santos RV; Magerl M; Mlynek A; Lima HC
    Ann Allergy Asthma Immunol; 2009 Jun; 102(6):495-9. PubMed ID: 19558008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of subsensitivity to loratadine during long-term dosing during 12 weeks.
    Bousquet J; Chanal I; Skassa-Brociek W; Lemonier C; Michel FB
    J Allergy Clin Immunol; 1990 Aug; 86(2):248-53. PubMed ID: 1974561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind comparison of loratadine (SCH 29851), astemizole, and placebo in hay fever with special regard to onset of action.
    Oei HD
    Ann Allergy; 1988 Dec; 61(6):436-9. PubMed ID: 2904776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsedating histamine H1-receptor antagonists.
    Mann KV; Crowe JP; Tietze KJ
    Clin Pharm; 1989 May; 8(5):331-44. PubMed ID: 2568212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.